Journals / Türk Yoğun Bakım Dergisi / 2016 / Cilt: 14 - Sayı: 1

Neurological Recovery after Amantadine Treatment in a Patient with Septic Arthritis: A Case Report

Septik Artritli Hastada Amantadin Kullanımı Sonrası Nörolojik Düzeltme: Olgu Sunumu

Pages
39–42
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result we believe that amantadine is an efficient agent in treatment of neurological patients with coma and significantly decrease rehabilitation duration

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this case report a patient with septic arthritis who developed impaired consciousness that responded to amantadine sulfate treatment was presented.
📊
Key Findings & Data:A 67 years old male patient who had high fever, leukocytosis, hypotension, and generalized organ failure findings after knee prosthesis revision surgery was accepted to intensive care unit.
💡
Conclusion & Impact:As a result we believe that amantadine is an efficient agent in treatment of neurological patients with coma and significantly decrease rehabilitation duration
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this case report a patient with septic arthritis who developed impaired consciousness that responded to amantadine sulfate treatment was presented. A 67 years old male patient who had high fever, leukocytosis, hypotension, and generalized organ failure findings after knee prosthesis revision surgery was accepted to intensive care unit. Patient was intubated and connected to mechanical ventilation as he lost consciousness during non-invasive mechanical ventilation. In the follow-up he was diagnosed with bone abscess and was started penicillin according to culture results. Despite of clinical and laboratory resolving of sepsis finding, patient had tonic-clonic seizures especially on the right upper extremity with normal cranial computerized tomography findings. Septic course of the patient improved with antibiotic treatment, while impaired consciousness and seizures continued. Radiological evaluation of the patient was within normal ranges; however he was diagnosed as organic neurological dysfunction that developed secondary to sepsis. Amantadine sulfate 200 mg/day was initiated after neurology department consultation. Neurological suppression and seizures started to improve after the 6th day and completely resolved after the 10th day of the treatment. Patient was discharged from intensive care unit after resolution of septic clinic after 57 days. As a result we believe that amantadine is an efficient agent in treatment of neurological patients with coma and significantly decrease rehabilitation duration

Özet

Septik artrit nedeniyle takip ettiğimiz ve bilinç bozukluğu gelişen bir hastanın amantadin sülfat tedavisine yanıtını sunmayı amaçladık. Altmış yedi yaşında erkek hasta diz protezi revizyonu ameliyatı sonrası yüksek ateş, lökositoz, hipotansiyon ve organ yetmezliği bulguları nedeniyle sepsis tanısıyla yoğun bakım ünitesine kabul edildi. Hasta bilinci kapanması üzerine entübe edilerek mekanik ventilatör desteğine alındı. Kemik absesi saptanan ve kültür üremelerine göre penisilin antibiyotik tedavisi verilen hastanın takibinde özellikle sağ üst ekstremitede tonik-klonik nöbeti oldu. Çekilen kraniyal bilgisayarlı tomografi normal olarak değerlendirildi. Antibiyotik tedavisi altında septik tablosu düzelen hastanın bilinç bozukluğu ve nöbetleri devam etti. Radyolojik incelemeleri normal sınırlarda saptanan hasta sepsis zemininde nörolojik fonksiyon bozukluğu olarak tanı aldı. Nöroloji tarafından amantadin sülfat 200 mg infüzyon şeklinde başlandı ve 6. günden itibaren bilinç durumu olumlu yönde değişen hastanın bilinci 10. günde normal sınırlara geldi. Yoğun bakıma yatışının 57. gününde servise taburcu edildi. Amantadin tedavisi koma hastalarında nörolojik iyileşmeyi hızlandırdığını ve rehabilitasyon sürecinde etkili olduğu kanısındayız

🔖

Cite This Article

BAYKAL, Z. T., ÖZAYAR, E., KENAN, İ., BABAYİĞİT, M., GÖKHANER, M. Ş., HORASANLI, E. (2016). Neurological Recovery after Amantadine Treatment in a Patient with Septic Arthritis: A Case Report. Türk Yoğun Bakım Dergisi, Cilt: 14 - Sayı: 1, 39–42. https://ajindex.com/articles/327820

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Horváth K, Aschermann Z, Komoly S, Kovács A, Kovács N. Treatment of tardive syndromes. Psychiatr Hung 2014;29:214-4.
  2. Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, et al. Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology 1996;46:1551-6.
  3. Giacino JT, Whyte J, Bagiella E, Kalmar K, Childs N, Khademi A, et al. Placebo- controlled trial of amantadine for severe traumatic brain injury. N Engl J Med 2012;366:819-26.
  4. Atila S, Alagöz ZA. Roles of NMDA receptor antagonists in neuropathic pain. J Fac Pharm 2010;39:51-68.
  5. Saniova B, Drobny M, Kneslova L, Minarik M. The outcome of patients with severe head injuries treated with amantadine sulphate. J Neurol Transm (Vienna) 2004;111:511-4.
  6. Aksu NM, Şenlikçi H, Akkaş M, Özmen MM. The neurological improvement of a patient after amantadine infusion. JAEMCR 2013;4:161-3.
  7. Chandler MC, Barnhill JL, Gualtieri CT. Amantadine for the agitated head injury patient. Brain Inj 1988;2:309-11.
  8. Gualtieri T, Chandler M, Coons TB, Brown LT. Amantadine: A new clinical profile for traumatic brain injury. Clin Neuropharmacol 1989;12:258-70.
  9. Saniova B, Drobny M, K neslova L, Minarik M. The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm (Vienna) 2004;111:511-4.
  10. Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother 2008;42:247-52.
  11. Nickels JL, Schneider WN, Dombovy ML, Wong TM. Clinical use of amantadine in brain injury rehabilitation. Brain Inj 1994;8:709-18.
  12. Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, et al. Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial. Neurolgy 2014;82:300-7.
  13. Sutter R, Kaplan PW. Electroencephalographic criteria for nonconvulsive status epilepticus; synopsis and comprehensive survey. Epilepsia 2012;53(Suppl 3):1-51.